<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T15:54:40Z</responseDate><request verb="GetRecord" identifier="oai:repository.ajou.ac.kr:201003/4364" metadataPrefix="oai_dc">https://repository.ajou.ac.kr/oai/request</request><GetRecord><record><header><identifier>oai:repository.ajou.ac.kr:201003/4364</identifier><datestamp>2024-10-11T02:17:39Z</datestamp><setSpec>com_201003_14369</setSpec><setSpec>com_201003_14368</setSpec><setSpec>col_201003_14371</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Comparison of the Incidence and Severity of Cough after Alfentanil and Remifentanil Injection</dc:title>
<dc:title>Alfentanil과 remifentanil 정주 후 나타나는 기침의 발생 빈도와 정도 비교</dc:title>
<dc:creator>조, 한범</dc:creator>
<dc:contributor>이, 숙영</dc:contributor>
<dc:contributor>대학원 의학과</dc:contributor>
<dc:contributor>104247</dc:contributor>
<dc:contributor>조, 한범</dc:contributor>
<dc:subject>alfentanil</dc:subject>
<dc:subject>remifentanil</dc:subject>
<dc:subject>opioid induced cough</dc:subject>
<dc:description>Introduction: Intravenous administration of fentanyl derivatives can induce cough paradoxically. This study examined the incidence and severity of cough after a bolus of alfentanil and remifentanil. 

Methods: Four-hundred sixty five patients, aged 18-70 years, were allocated randomly to three groups to receive alfentanil 10 μg/kg, remifentanil 1 μg/kg, or an equal volume of 0.9% saline intravenously over 10 s. Any episode of cough was classified as coughing and graded as mild (1-2), moderate (3-4) or severe (5 or more). 

Results: The overall incidence of cough was higher in the opioid groups than the saline group. The remifentanil group [39/150 patients; 26.0%, (95% CI, 19.6-33.6%)] showed a higher incidence than the alfentanil group [11/152 patients; 7.2%, (95% CI, 0.4-12.6%)] (P &lt; 0.001). There was no significant difference in the severity of cough between alfentanil and remifentanil group. 

Conclusion: This study demonstrated that the equipotent boluses of alfentanil and remifentanil induced coughing, even though the incidence of cough after alfentanil administration was lower than that after remifentanil administration.</dc:description>
<dc:description>ABSTRACT i

TABLE OF CONTENTS ii

LIST OF TABLES iii

LIST OF FIGURE iv

ABBREVIATIONS v

I. INTRODUCTION 1

II. PATIENTS AND METHODS 3

III. RESULTS 5

IV. DISCUSSION 12

REFERENCES 17

국문요약 21</dc:description>
<dc:description>Doctor</dc:description>
<dc:date>2011-11-07T04:22:47Z</dc:date>
<dc:date>2011-11-07T04:22:47Z</dc:date>
<dc:date>2011</dc:date>
<dc:date>2011</dc:date>
<dc:type>Thesis</dc:type>
<dc:type>Theses</dc:type>
<dc:identifier>http://repository.ajou.ac.kr/handle/201003/4364</dc:identifier>
<dc:identifier>http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000011484</dc:identifier>
<dc:identifier>000000011484</dc:identifier>
<dc:language>en</dc:language>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>